Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli.
about
Respiratory health hazards in agricultureRecognition of Staphylococcus aureus by the innate immune system.Alpha-2-macroglobulin functions as an inhibitor of fibrinolytic, clotting, and neutrophilic proteinases in sepsis: studies using a baboon modelStaphylococcus aureus - induced tumor necrosis factor - related apoptosis - inducing ligand expression mediates apoptosis and caspase-8 activation in infected osteoblastsThe role of complement system in septic shockAn inflammatory polypeptide complex from Staphylococcus epidermidis: isolation and characterization.Interleukin-1 (IL-1) receptor antagonist prevents Staphylococcus epidermidis-induced hypotension and reduces circulating levels of tumor necrosis factor and IL-1 beta in rabbitsInduction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans.The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failureCommercial preparations of lipoteichoic acid contain endotoxin that contributes to activation of mouse macrophages in vitroDifferential tumor necrosis factor alpha expression and release from peritoneal mouse macrophages in vitro in response to proliferating gram-positive versus gram-negative bacteria.Cytokine appearance and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection.Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes.Induction of tumor necrosis factor alpha by the group- and type-specific polysaccharides from type III group B streptococci.Serum-induced potentiation of tumor necrosis factor alpha production by human monocytes in response to staphylococcal peptidoglycan: involvement of different serum factorsStaphylococcal glycocalyx activates macrophage prostaglandin E2 and interleukin 1 production and modulates tumor necrosis factor alpha and nitric oxide production.Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in miceCapsular polysaccharide types 5 and 8 of Staphylococcus aureus bind specifically to human epithelial (KB) cells, endothelial cells, and monocytes and induce release of cytokines.Streptococcus mitis cell walls and lipopolysaccharide induce lethality in D-galactosamine-sensitized mice by a tumor necrosis factor-dependent pathway.Roles of the bacterial cell wall and capsule in induction of tumor necrosis factor alpha by type III group B streptococci.The effect of dexmedetomidine on inflammatory response of septic rats.Lipoteichoic acid induces secretion of interleukin-8 from human blood monocytes: a cellular and molecular analysisTherapeutic potential of targeting IL-1 and IL-18 in inflammation.Association of tumor necrosis factor β genetic polymorphism and sepsis susceptibilityMolecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses.Variation of Circulating Inflammatory Mediators in Staphylococcus aureus and Escherichia coli Bloodstream Infection.Coagulase-negative staphylococci in multiple blood cultures: strain relatedness and determinants of same-strain bacteremiaDexmedetomidine inhibits inflammatory reaction in lung tissues of septic rats by suppressing TLR4/NF-κB pathway.Identification of tumor necrosis factor as a transcriptional regulator of the phosphoenolpyruvate carboxykinase gene following endotoxin treatment of mice.Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophagesCordelia, Goneril and the febrile response.Fulminant liver failure model with hepatic encephalopathy in the mouse.Isolation and characterization of a highly specific serine endopeptidase from an oral strain of Staphylococcus epidermidis.Increased interleukin-1 (IL-1) and imbalance between IL-1 and IL-1 receptor antagonist during acute inflammation in experimental Shigellosis.Interaction of cationic peptides with lipoteichoic acid and gram-positive bacteriaDifferential roles of interleukin-18 (IL-18) and IL12 for induction of gamma interferon by staphylococcal cell wall components and superantigens.Peptidoglycan from Staphylococcus aureus induces tissue factor expression and procoagulant activity in human monocytesPrevention of experimental endotoxin shock by a monocyte activator.Supernatants from Staphylococcus epidermidis grown in the presence of different antibiotics induce differential release of tumor necrosis factor alpha from human monocytesInduction of nitric oxide production by polyosides from the cell walls of Streptococcus mutans OMZ 175, a gram-positive bacterium, in the rat aorta
P2860
Q23924480-AF089F9E-CBEA-4286-BDD5-DD09BB41739CQ24530569-89E86386-D7FF-48D2-BA1B-CE1F6976DE2CQ24656054-1A6BDB03-6465-4035-95BF-8821AE1E87CFQ24794331-2C99C080-102C-4A90-9279-AAAE05B782F8Q27027974-83EA44D9-862E-4C8B-B005-2F2AF34A8B3AQ30654626-52039B81-A06D-47E5-8AF9-A1D6D5542A18Q33493710-297D5905-DF70-45D2-BF04-E0BFBFAE9EACQ33610466-30421C08-4035-4FAF-BEFD-EA3918EB678BQ33838051-1BE61203-47DB-4316-A857-0AB466B6E020Q34005884-07D502E5-3C9B-456B-ACC9-E1F665DA18DAQ34007548-D1927B3A-4FC4-4B09-B066-9CE489D101EEQ34521810-F878D9D1-FB67-42A3-8CEA-DFDDEF746765Q34528810-598A0B4D-59F1-43CC-9A1B-19C89A142BB1Q34529051-AA9FABDC-CB06-4A91-850B-C1205D63444CQ34537002-79F7D138-E6E0-4C59-A709-3369CEE41E77Q34539452-D10ED533-FA7B-44F6-8F5F-FFE9C3B50FC3Q35397535-8649586E-DB74-46DC-B0C8-9EC20273E61CQ35401023-9C470CDA-06EE-4C7E-B379-23FD61C392E0Q35492787-01B8EF72-6858-41A0-8F39-6B1C5D980DFEQ35531363-A8FD40FB-926A-4824-9A2F-853765A7E945Q35619585-81925E48-8391-4672-9C24-79F13BE112ACQ35771239-96A3F8CE-E171-4A48-AA7E-4DEFAB6E9347Q35790840-A7BC0FBA-627A-44AC-915E-EA38117DF80FQ36230486-DB921DE7-4C71-46E1-B1EB-C4F55E7CEA49Q36365572-9AB5B0F3-BC28-4C37-AF62-057E68684479Q36482805-2A9BFF66-F922-4676-B348-FDCA47B336CAQ36520353-65922B51-451B-4BC9-AC32-96BD442B6543Q36831059-945B85C2-C0AF-4A09-AAB4-0671041A8F51Q36951482-42DB88D8-C956-4D4A-B4A1-01A0918AFC48Q37119939-B088E91A-38BB-4A65-A47E-4950647326CBQ38298905-6FD04735-D54A-4099-B373-21858D7710E8Q38354469-4E014557-8F34-42EB-87B5-A92624986418Q38524377-9EFB054B-C5F7-41A6-A07C-45D8EC044ABEQ39512878-CF8E4A8D-EB51-4828-8909-B1F75FBE0D1EQ39513309-0DD08968-CF37-4525-AF4D-47F1EAF6443FQ39521555-A1109B18-3DB7-484C-AE39-E02103249A73Q39655309-5BB53B4D-EE98-43FB-9327-9F0B32C1C8DFQ39780812-1DB98D27-D2E6-43EF-A380-7049585FF2F3Q39826356-8AE0DD85-AAC1-44D2-8697-95AFDB707143Q39830001-01513080-F450-43DF-B2FC-106946750898
P2860
Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli.
description
1991 nî lūn-bûn
@nan
1991 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
name
Staphylococcus epidermidis ind ...... omparison to Escherichia coli.
@ast
Staphylococcus epidermidis ind ...... omparison to Escherichia coli.
@en
type
label
Staphylococcus epidermidis ind ...... omparison to Escherichia coli.
@ast
Staphylococcus epidermidis ind ...... omparison to Escherichia coli.
@en
prefLabel
Staphylococcus epidermidis ind ...... omparison to Escherichia coli.
@ast
Staphylococcus epidermidis ind ...... omparison to Escherichia coli.
@en
P2093
P2860
P356
P1476
Staphylococcus epidermidis ind ...... omparison to Escherichia coli.
@en
P2093
C A Dinarello
G Wakabayashi
J A Gelfand
R J Connolly
P2860
P304
P356
10.1172/JCI115218
P407
P577
1991-06-01T00:00:00Z